Company: NDRA
Filing Date: 2025-10-28
Form Type: DEF 14A
Source: 0001654954-25-012254
Chunk: 3

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-28
Form: DEF 14A
Chunk 3
---
 |     | 16 |
| THE BOARD OF DIRECTORS AND ITS COMMITTEES                                                                                                                                                                              |     | 19 |
| PROPOSAL 2 - APPROVAL, ON AN ADVISORY BASIS, OF THE COMPANY’S EXECUTIVE COMPENSATION                                                                                                                                   |     | 21 |
| PROPOSAL 3 - RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM                                                                                                                              |     | 31 |
| REPORT OF THE AUDIT COMMITTEE                                                                                                                                                                                          |     | 31 |
| PROPOSAL 4 - APPROVAL OF AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION INCREASING THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 20,000,000 SHARES TO 1,000,000,000 SHARES                                    |     | 33 |
| PROPOSAL 5 - APPROVAL OF AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO UPDATE THE EXCULPATION PROVISION TO LIMIT THE LIABILITY OF CERTAIN OFFICERS OF THE COMPANY AS PERMITTED BY RECENT CHANGES TO DELAWARE LAW |     | 34 |
| PROPOSAL 6 – APPROVAL OF SECOND AMENDMENT TO 2016 OMNIBUS INCENTIVE PLAN                                                                                                                                               |     | 36 |
| CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS                                                                                                                                                                         |     | 46 |
| DELINQUENT SECTION 16(a) REPORTS                                                                                                                                                                                       |     | 47 |
| HOUSEHOLDING OF ANNUAL MEETING MATERIALS                                                                                                                                                                               |     | 47 |
| OTHER BUSINESS                                                                                                                                                                                                         |     | 47 |
| IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE STOCKHOLDER MEETING TO BE HELD ON DECEMBER 9, 2025                                                                                              |     | 47 |

| 5 |

<div align='center'>ENDRA Life Sciences Inc.

3600 Green Court, Suite 350

Ann Arbor, Michigan 48105

PROXY STATEMENT</div>

The Board of Directors (the “Board”) of ENDRA Life Sciences Inc. (the “Company,” “ENDRA,” “we,” “us” or “our”) is providing these materials to you in connection with ENDRA’s 2025 Annual Meeting of Stockholders (together with any adjournment or postponement thereof, the “2025 Annual Meeting”). The 2025 Annual Meeting will take place on December 9, 202